Consortium members
Rachna Agrawal, Ph.D.
Associate Director, Clinical Trial Analytics
Bristol Myers Squibb
Beth Mahon, J.D.
Senior Director, Head of Feasibility Center of Excellence
Janssen | Johnson
& Johnson
Sandra Smyth
Senior Director, Global Feasibility and Site Intelligence, Dev. Ops.
AstraZeneca
Our ZS team
Vitaly Bourenin
Decision Analytics
Associate Consultant
Consortium Coordinator
Akanksha Sharma
Knowledge Services
Associate Consultant
Consortium Coordinator
Zach Sawaged, M.S.
Business Technology Solutions Associate Consultant
Consortium Co-Lead
Jonathan Rowe, Ph.D.
Principal, R&D Quality and
Risk Management Lead
Mike Martin, MBA
Principal, Clinical Development Excellence Lead
Ronald Du
Associate Principal,
Clinical Development Excellence
Consortium Member
* Consortium Chair/ Vice Chair
Shelley Liu
Strategy Insights &
Planning Associate Consultant
Consortium Lead
Jenny Higley
Director, Head of Feasibility CoE
Biogen
John Austin
Director, Advanced Analytics
Gilead
Veronica Loitegui
Senior Director, Global Feasibility Immunology
BMS
Kim Sholuade (nee Sowemimo)
Director, Global Feasibility
TA Head
Johnson & Johnson
Michele Teufel
Senior Director, TA Strategy & Portfolio Delivery
AstraZeneca
Sven Oechsner
Head, Feasibility
Intelligence
Bayer
Erika Meloche
Associate Director, Clinical Operations Planning & Feasibility
GSK
Sarah McClure
Global Data
Engagement Lead
Sanofi
Dana Iommazzo*
Global Head, Clinical Operations
Program Management
Novartis
Anup Somayaji
Director, Development Data & Analytics
Amgen
Amy Froment
Senior Director, Head, Global Trial Optimization
Regeneron
Ronald Du
Associate Principal,
Clinical Development Excellence
ZS
Katherine Broecker*
Senior Director, Clinical Trial Design Capabilities
Eli Lilly
Michael Dawson
Director,
Study Feasibility
AbbVie
Angie Chen, Ph.D., PMP
Senior Director, Strategic Operations
BeOne
CJ Chen
Feasibility Strategy Lead, Clinical Operations Program Management
Novartis
Michelle Everill
VP, Global Trial Optimization
Alnylam Pharmaceuticals
Daniel Portilla
Senior Director, Clinical Business Operations
Acadia Pharmaceuticals
Dan Watson
Director, Clinical
Operations - Therapeutic Area Lead, Rare Disease
Acadia
Kelly White
Head, Global Trial Optimization
Merck
Ishita Srivastava
Knowledge Services Consultant
Consortium Coordinator
Katie Bonner
Director, Strategic Feasibility Biopharmaceuticals – Respiratory and Immunology
AstraZeneca
Eva Gorree
Director, Global
Feasibility Head Immunology
JBVNL
Adam Linkov
Director, Global Trial Optimization
Regeneron
Sarah McClure
Global Data
Engagement Lead
Sanofi
Greg Senior
Director, Global Trial Optimization
Merck
Vivek Trivedi
Director - Patient Engagement Data Insights
Eli Lilly
Sven Oechsner
Head, Feasibility
Intelligence
Bayer
Stephanie Vakaljan
Director Clinical Operations Decision Analytics (CODA)
GlaxoSmithKline
Alex Weir
Senior Director & Head of Operational Design
Amgen
Alex Westbury
Director, R&D Clinical
Trial Analytics
Merck
Morgan Wooten
Director, Head of Patient Engagement, Recruitment
and Retention
Daiichi Sankyo
John Yannone
Director, Global
Feasibility Strategy
Johnson & Johnson Innovation Medicine
Daniel Young
Director | Head of Trial
Feasibility & Site Identification
Daiichi Sankyo
